Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats

BACKGROUND: Although dopamine D(2) receptor agonists, bromocriptine and cabergoline, are notable medications in the treatment of Parkinsonism, hyperprolactinemia, and hyperglycemia, there is an identified relationship between the utilization of D(2)-like R agonists and the progress of myocardial inj...

Descripción completa

Detalles Bibliográficos
Autores principales: Fouad Shalaby, Mohammed, Latif, Hekma A. Abd El, Yamani, Mohamed El, Galal, May Ahmed, Kamal, Sherifa, Sindi, Ikhlas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577162/
https://www.ncbi.nlm.nih.gov/pubmed/34777640
http://dx.doi.org/10.1016/j.curtheres.2021.100647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577162/
https://www.ncbi.nlm.nih.gov/pubmed/34777640
http://dx.doi.org/10.1016/j.curtheres.2021.100647

Ejemplares similares